Skip to the page

Data / Drug companies / Armas Pharmaceuticals Inc.

Armas Pharmaceuticals Inc.: 68 products in the FDA NDC directory, labeler code 72485

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Armas Pharmaceuticals Inc. (labeler code 72485) lists 68 products in the FDA National Drug Code Directory, covering 44 finished drugs by generic name. By type: 67 prescription drugs, 1 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 21, 2026.

The request: Watch Armas Pharmaceuticals Inc. (FDA labeler code 72485): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
72485
Products in commercial distribution
68
Packages
87
Finished drugs by generic name
44
Prescription products
67
Over the counter products
1
Flagged as original packager
63 of 63 products that carry the flag
Started marketing in the last 12 months
11
Earliest marketing start
September 10, 2018
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)68100%

Products by type

TypeProductsShare
Prescription drugs6798.5%
Over the counter drugs11.5%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Injection1927.9%
Injection, solution1522.1%
Injection, powder, for solution1116.2%
Tablet, film coated710.3%
Injection, powder, lyophilized, for solution45.9%
Solution/ drops45.9%
Suspension/ drops34.4%
Solution22.9%
Jelly11.5%
Gel11.5%
Ointment11.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Ziprasidone Mesylate 20 mg/mL72485-430Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 21, 2026
Carboprost Tromethamine72485-525Injection, solutionGeneric drugs (ANDA)September 15, 2026
Labetalol Hydrochloride72485-515Injection, solutionGeneric drugs (ANDA)September 15, 2026
Erythromycin Lactobionate72485-701Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)July 9, 2026
Desmopressin Acetate72485-524Injection, solutionGeneric drugs (ANDA)June 30, 2026
Desmopressin Acetate72485-523Injection, solutionGeneric drugs (ANDA)June 30, 2026
Ropivacaine Hydrochloride72485-519InjectionGeneric drugs (ANDA)June 1, 2026
Sumatriptan72485-518Injection, solutionGeneric drugs (ANDA)June 1, 2026
Haloperidol Decanoate72485-522InjectionGeneric drugs (ANDA)May 15, 2026
Haloperidol Decanoate72485-521InjectionGeneric drugs (ANDA)May 15, 2026
Haloperidol Decanoate72485-520InjectionGeneric drugs (ANDA)May 15, 2026
Ampicillin72485-423Injection, powder, for solutionGeneric drugs (ANDA)May 1, 2025
Ampicillin Sodium and Sulbactam Sodium72485-418Injection, powder, for solutionGeneric drugs (ANDA)May 1, 2025
Dexamethasone Sodium Phosphate72485-118Injection, solutionGeneric drugs (ANDA)April 22, 2025
Lidocaine72485-611JellyGeneric drugs (ANDA)March 2, 2025
Cisatracurium Besylate72485-513InjectionGeneric drugs (ANDA)January 15, 2025
Nicardipine Hydrochloride72485-116InjectionGeneric drugs (ANDA)April 3, 2024
Tranexamic Acid72485-510InjectionGeneric drugs (ANDA)February 6, 2024
Etomidate72485-509Injection, solutionGeneric drugs (ANDA)January 22, 2024
Etomidate72485-508Injection, solutionGeneric drugs (ANDA)January 22, 2024
Ampicillin72485-421Injection, powder, for solutionGeneric drugs (ANDA)November 10, 2023
Brimonidine Tartrate/Timolol Maleate72485-634Solution/ dropsGeneric drugs (ANDA)November 3, 2023
Ciprofloxacin and dexamethasone72485-625Suspension/ dropsGeneric drugs (ANDA)November 1, 2023
Nafcillin sodium72485-406Injection, powder, for solutionGeneric drugs (ANDA)November 1, 2023
Nafcillin sodium72485-405Injection, powder, for solutionGeneric drugs (ANDA)November 1, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.